This article is part of the April 2018 edition of ASBMT eNews. Download the full issue here.
Register today for the 4th International Workshop on Biology, Prevention and Treatment of Relapse after HSCT, taking place September 21-22, 2018 in Chicago.
Relapse and disease progression are the leading causes of treatment failure for most hematologic malignancies treated with hematopoietic stem-cell transplantation. Be sure to attend this workshop, which will:
- Provide an update on the current state of the science relative to biology and clinical study of relapse related to both autologous and allogeneic HSCT.
- Provide a forum for the presentation of ongoing laboratory and translational research specifically related to relapse following HSCT.
- Provide a forum to present ongoing clinical trials that are specific to the study of and treatment of relapse following HSCT.
- Provide an overview of the potential role of CAR T-cells and other cellular therapies in the prevention and treatment of relapse following HSCT.
For more information, visit www.relapse-after-hsct.com.